Effect of Cervicothoracic Mobilization on Upper Crossed Syndrome
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
PURPOSE: To investigate the effect of cervicothoracic mobilization on Craniovertebral angle (CVA), sagittal shoulder angle (SSA), kyphotic angle and pain intensity level in upper crossed syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2022
CompletedFirst Posted
Study publicly available on registry
December 27, 2022
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedApril 11, 2023
April 1, 2023
4 months
December 16, 2022
April 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
change in Craniovertebral angle (CVA) .
Craniovertebral angle (CVA) will be measured using Computerized photogrammetry is utilized markers, Digital camera and Kinovea software.
before treatment,and after eight weeks of treatment.
change in Sagittal shoulder angle (SSA).
Sagittal shoulder angle (SSA) will be measured using Computerized photogrammetry is utilized markers, Digital camera and Kinovea software.
before treatment,and after eight weeks of treatment.
change in thoracic kyphosis angle.
thoracic kyphosis angle will be measured using the flexicurve ruler
before treatment,and after eight weeks of treatment.
change in pain level
pain severity will be measured using visual analogue scale Each participant will be asked to put a mark on a 10-cm horizontal line that is marked with 'zero' at one end to indicate no pain and marked with'10' at the other end to indicate maximum pain.
before treatment,and after eight weeks of treatment.
Study Arms (2)
cervicothoracic mobilization
EXPERIMENTALThis group will receive cervicothoracic mobilization with comprehensive corrective exercise
control group: comprehensive corrective exercise (CCE).
ACTIVE COMPARATORThis group will receive traditional treatment comprehensive corrective exercise (CCE).
Interventions
Each participant in study group will receive cervicothoracic mobilization (central PA and transverse Grade III or grade IV) with comprehensive corrective exercise. The duration will eight weeks three sessions per week.
Each participant will receive comprehensive corrective exercise include three phases: Initial phase -Improvement phase and Maintenance phase. The initial phase exercises progress in frequency and intensity during this phase, as long as participants are able to demonstrate good quality movement. The initial phase duration is 2 weeks and the exercises will be performed for seven sets of 10-s hold . Improvement phase exercises are progressed by considering individual characteristics of each participant and by observing the overload principle and the progression in the number of repetitions of each set during the 4 weeks of the improvement phase. The exercises will be performed from five sets of ten repetitions to six sets of 15 repetitions . Maintenance phase exercises:The exercises are the same as in the improvement phase without any progression in intensity and frequency. The maintenance phase duration is 2 weeks
Eligibility Criteria
You may qualify if:
- Age between 20-50 years .
- Participants will included if their CVA less than 48° ( SSA less than 52°) , as above these values are considered normal and thoracic kyphosis (with flexicurve angle more than 45 degrees) .
- Subjects who have weakness in deep neck flexors, serratus anterior, middle and lower trapezius and rhomboid muscles and tightness in upper trapezius, levator scapulae, scalene, posterior neck and suboccipital muscles, pectoralis major and minor and sternocleidomastoid muscles.
- Subject complaining of this symptom for more than 3mothes.
- Marking pain intensity score visual analog scale (VAS) ≥3 in neck and shoulder
You may not qualify if:
- History of surgery or joint diseases of the spine or shoulder.
- Osteoporosis, or fracture ,cervical instability or any sign those with other contraindications against joint mobilization.
- Individuals with any cervical condition e.g. radiculopathy, cervical rib, whiplash injury and individuals with any neurological/ condition .
- History of congenital spinal deformity (congenital scoliosis) .
- Any malignancy related to soft tissue and joints .
- Subjects taking analgesics and/or muscle relaxants.
- pregnancy.
- Being in weight out of the normal range (18 ≥ BMI ≥ 25).
- Cognitive impairment and inability to understand the scale.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Related Publications (1)
Seidi F, Bayattork M, Minoonejad H, Andersen LL, Page P. Comprehensive corrective exercise program improves alignment, muscle activation and movement pattern of men with upper crossed syndrome: randomized controlled trial. Sci Rep. 2020 Nov 26;10(1):20688. doi: 10.1038/s41598-020-77571-4.
PMID: 33244045BACKGROUND
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Abeer Yamany, professor
Professor of physical therapy, Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer of physical therapy-Benha University
Study Record Dates
First Submitted
December 16, 2022
First Posted
December 27, 2022
Study Start
April 1, 2023
Primary Completion
August 1, 2023
Study Completion
September 1, 2023
Last Updated
April 11, 2023
Record last verified: 2023-04